However, obeticholic acid, a farnesoid X nuclear receptor (FXR) ligand that modulates lipid metabolism, has been associated with improvement in the liver histology of patients with NASH, and also with significant decreases in AST, ALT, γ-GT, and total bilirubin [38]. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.